MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.
1
Funding Rounds
$4.2m
Money raised
The company MiMARK has raised a total of $4.2m in funding over 1 rounds.